1,275
Views
15
CrossRef citations to date
0
Altmetric
Research Article

Enhancement of cisplatin-based TACE by a hemoglobin-based oxygen carrier in an orthotopic rat HCC model

, , , , , , , , & show all
Pages 229-236 | Received 22 Mar 2013, Accepted 14 May 2013, Published online: 25 Jun 2013

References

  • Braun RD, Lanzen JL, Snyder SA, Dewhirst MW. 2001. Comparison of tumor and normal tissue oxygen tension measurements using OxyLite or microelectrodes in rodents. Am J Physiol Heart Circ Physiol. 280:H2533–H2544.
  • Bruix J, Sala M, Llovet JM. 2004. Chemoembolization for hepato-cellular carcinoma. Gastroenterology. 127:S179–S188.
  • Carlsson G, Gullberg B, Hafstrom L. 1983. Estimation of liver tumor volume using different formulas - an experimental study in rats. J Cancer Res Clin Oncol. 105:20–23.
  • Chen L, Yuan YF, Li Y, Chan TH, Zheng BJ, Huang J, Guan XY. 2011. Clinical significance of CHD1L in hepatocellular carcinoma and therapeutic potentials of virus-mediated CHD1L depletion. Gut. 60:534–543.
  • Cheng Q, Ng KT, Fan ST, Lim ZX, Guo DY, Liu XB, et al. 2010. Distinct mechanism of small-for-size fatty liver graft injury–Wnt4 signaling activates hepatic stellate cells. Am J Transplant. 10:1178–1188.
  • Elas M, Ahn KH, Parasca A, Barth ED, Lee D, Haney C, Halpern HJ. 2006. Electron paramagnetic resonance oxygen images correlate spatially and quantitatively with Oxylite oxygen measurements. Clin Cancer Res. 12:4209–4217.
  • Fu HY, Minamino T, Tsukamoto O, Sawada T, Asai M, Kato H, et al. 2008. Overexpression of endoplasmic reticulum-resident chaperone attenuates cardiomyocyte death induced by proteasome inhibition. Cardiovasc Res. 79:600–610.
  • Gately DP, Jones JA, Christen R, Barton RM, Los G, Howell SB. 1994. Induction of the growth arrest and DNA damage-inducible gene GADD153 by cisplatin in vitro and in vivo. Br J Cancer. 70: 1102–1106.
  • Griffiths JR, Robinson SP. 1999. The OxyLite: a fibre-optic oxygen sensor. Br J Radiol. 72:627–630.
  • Gundersen SI, Palmer AF. 2008. Hemoglobin-based oxygen carrier enhanced tumor oxygenation: a novel strategy for cancer therapy. Biotechnol Prog. 24:1353–1364.
  • Huang LW, Lin CY, Lee CC, Liu TZ, Jeng CJ. 2012. Overexpression of GRP78 Is Associated with Malignant Transformation in Epithelial Ovarian Tumors. Appl Immunohistochem Mol Morphol. 20: 381–385.
  • Janssen HL, Haustermans KM, Balm AJ, Begg AC. 2005. Hypoxia in head and neck cancer: how much, how important?Head Neck. 27:622–638.
  • Kennedy KA, Teicher BA, Rockwell S, Sartorelli AC. 1980. The hypoxic tumor cell: a target for selective cancer chemotherapy. Biochem Pharmacol. 29:1–8.
  • Knisely JP, Rockwell S. 2002. Importance of hypoxia in the biology and treatment of brain tumors. Neuroimaging Clin N Am. 12:525–536.
  • Li J, Holbrook NJ. 2004. Elevated gadd153/chop expression and enhanced c-Jun N-terminal protein kinase activation sensitizes aged cells to ER stress. Exp Gerontol. 39:735–744.
  • Linberg R, Conover CD, Shum KL, Shorr RG. 1998. Increased tissue oxygenation and enhanced radiation sensitivity of solid tumors in rodents following polyethylene glycol conjugated bovine hemoglobin administration. In Vivo.12:167–173.
  • Llovet JM, Bruix J. 2003. Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival. Hepatology. 37:429–442.
  • Llovet JM, Real MI, Montana X, Planas R, Coll S, Aponte J, et al. 2002. Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial. Lancet. 359:1734–1739.
  • Lo CM, Ngan H, Tso WK, Liu CL, Lam CM, Poon RT, et al. 2002. Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma. Hepatology. 35:1164–1171.
  • Maataoui A, Qian J, Vossoughi D, Khan MF, Oppermann E, Bechstein WO, Vogl TJ. 2005. Transarterial chemoembolization alone and in combination with other therapies: a comparative study in an animal HCC model. Eur Radiol. 15:127–133.
  • Man K, Ng KT, Lo CM, Ho JW, Sun BS, Sun CK, et al. 2007. Ischemia-reperfusion of small liver remnant promotes liver tumor growth and metastases–activation of cell invasion and migration pathways. Liver Transpl. 13:1669–1677.
  • McCullough KD, Martindale JL, Klotz LO, Aw TY, Holbrook NJ. 2001. Gadd153 sensitizes cells to endoplasmic reticulum stress by down-regulating Bcl2 and perturbing the cellular redox state. Mol Cell Biol. 21:1249–1259.
  • Oyadomari S, Mori M. 2004. Roles of CHOP/GADD153 in endoplasmic reticulum stress. Cell Death Differ. 11:381–389.
  • Pino SC, O'sullivan-Murphy B, Lidstone EA, Yang C, Lipson KL, Jurczyk A, et al. 2009. CHOP mediates endoplasmic reticulum stress-induced apoptosis in Gimap5-deficient T cells. PLoS One. 4:e5468.
  • Pleguezuelo M, Marelli L, Misseri M, Germani G, Calvaruso V, Xiruochakis E, et al. 2008. TACE versus TAE as therapy for hepatocellular carcinoma. Expert Rev Anticancer Ther. 8:1623–1641.
  • Pyrko P, Schonthal AH, Hofman FM, Chen TC, Lee AS. 2007. The unfolded protein response regulator GRP78/BiP as a novel target for increasing chemosensitivity in malignant gliomas. Cancer Res. 67:9809–9816.
  • Rabik CA, Fishel ML, Holleran JL, Kasza K, Kelley MR, Egorin MJ, Dolan ME. 2008. Enhancement of cisplatin [cis-diammine dichloroplatinum (II)] cytotoxicity by O6-benzylguanine involves endoplasmic reticulum stress. J Pharmacol Exp Ther. 327:442–452.
  • Robinson MF, Dupuis NP, Kusumoto T, Liu F, Menon K, Teicher BA. 1995. Increased tumor oxygenation and radiation sensitivity in two rat tumors by a hemoglobin-based, oxygen-carrying preparation. Artif Cells Blood Substit Immobil Biotechnol. 23:431–438.
  • Sangro B, Rios R, Bilbao I, Beloqui O, Herrero JI, Quiroga J, Prieto J. 2002. Efficacy and toxicity of intra-arterial cisplatin and etoposide for advanced hepatocellular carcinoma. Oncology. 62:293–298.
  • Siddik ZH. 2003. Cisplatin: mode of cytotoxic action and molecular basis of resistance. Oncogene. 22:7265–7279.
  • Song X, Liu X, Chi W, Liu Y, Wei L, Wang X, Yu J. 2006. Hypoxia-induced resistance to cisplatin and doxorubicin in non-small cell lung cancer is inhibited by silencing of HIF-1alpha gene. Cancer Chemother Pharmacol. 58:776–784.
  • Teicher BA. 1994. Hypoxia and drug resistance. Cancer Metastasis Rev. 13:139–168.
  • Teicher BA, Dupuis NP, Emi Y, Ikebe M, Kakeji Y, Menon K. 1995. Increased efficacy of chemo- and radio-therapy by a hemoglobin solution in the 9L gliosarcoma. In Vivo. 9:11–18.
  • Urano M, Chen Y, Humm J, Koutcher JA, Zanzonico P, Ling C. 2002. Measurements of tumor tissue oxygen tension using a time-resolved luminescence-based optical oxylite probe: comparison with a paired survival assay. Radiat Res. 158:167–173.
  • Vikram DS, Bratasz A, Ahmad R, Kuppusamy P. 2007. A comparative evaluation of EPR and OxyLite oximetry using a random sampling of pO(2) in a murine tumor. Radiat Res. 168:308–315.
  • Wang HQ, Du ZX, Zhang HY, Gao DX. 2007. Different induction of GRP78 and CHOP as a predictor of sensitivity to proteasome inhibitors in thyroid cancer cells. Endocrinology. 148:3258–3270.
  • Wang XZ, Lawson B, Brewer JW, Zinszner H, Sanjay A, Mi LJ, et al. 1996. Signals from the stressed endoplasmic reticulum induce C/EBP-homologous protein (CHOP/GADD153). Mol Cell Biol. 16:4273–4280.
  • Wen B, Urano M, Humm JL, Seshan VE, Li GC, Ling CC. 2008. Comparison of Helzel and OxyLite systems in the measurements of tumor partial oxygen pressure (pO2). Radiat Res. 169:67–75.
  • Yu M, Dai M, Liu Q, Xiu R. 2007. Oxygen carriers and cancer chemo- and radiotherapy sensitization: bench to bedside and back. Cancer Treat Rev. 33:757–761.
  • Zinszner H, Kuroda M, Wang X, Batchvarova N, Lightfoot RT, Remotti H, et al. 1998. CHOP is implicated in programmed cell death in response to impaired function of the endoplasmic reticulum. Genes Dev. 12:982–995.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.